» Articles » PMID: 25186613

Interactions Between Neutrophils and Non-small Cell Lung Cancer Cells: Enhancement of Tumor Proliferation and Inflammatory Mediator Synthesis

Abstract

The inflammatory tumor microenvironment plays a crucial role in tumor progression. In lung cancer, both bacterial infections and neutrophilia are associated with a poor prognosis. In this study, we characterized the effect of isolated human neutrophils on proliferation of the non-small cell lung cancer (NSCLC) cell line A549 and analyzed the impact of A549-neutrophil interactions on inflammatory mediator generation in naive and lipopolysaccharide (LPS)-exposed cell cultures. Co-incubation of A549 cells with neutrophils induced proliferation of resting and LPS-exposed A549 cells in a dose-dependent manner. In transwell-experiments, this effect was demonstrated to depend on direct cell-to-cell contact. This pro-proliferative effect of neutrophils on A549 cells could be attenuated by inhibition of neutrophil elastase activity, but not by oxygen radical neutralization. Correspondingly, neutrophil elastase secretion, but not respiratory burst, was specifically enhanced in co-cultures of A549 cells and neutrophils. Moreover, interference with COX-2 activity by indomethacin or the specific COX-2 inhibitor NS-398 also blunted the increased A549 proliferation in the presence of neutrophils. In parallel, a massive amplification of COX-2-dependent prostaglandin E2 synthesis was detected in A549-neutrophil co-cultures. These findings suggest that direct cell-cell interactions between neutrophils and tumor cells cause release of inflammatory mediators which, in turn, may enhance tumor growth in NSCLC.

Citing Articles

Comparison of Prognostic Values of Seven Immune Indexes in Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab: How Effective Can They Be Regarding Our Treatment Decisions?.

Ulas A, Temel B, Kos F Medicina (Kaunas). 2024; 60(11).

PMID: 39596977 PMC: 11596302. DOI: 10.3390/medicina60111792.


COX-2 in lung cancer: Mechanisms, development, and targeted therapies.

Liu X, Zhang J, Sun W, Cao J, Ma Z Chronic Dis Transl Med. 2024; 10(4):281-292.

PMID: 39429482 PMC: 11483542. DOI: 10.1002/cdt3.120.


Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy.

Wen J, Liu D, Zhu H, Shu K J Neuroinflammation. 2024; 21(1):226.

PMID: 39285276 PMC: 11406851. DOI: 10.1186/s12974-024-03222-4.


Prognostic patterns in invasion lymph nodes of lung adenocarcinoma reveal distinct tumor microenvironments.

Lao S, Chen Z, Wang W, Zheng Y, Xiong S, He P NPJ Precis Oncol. 2024; 8(1):164.

PMID: 39080406 PMC: 11289302. DOI: 10.1038/s41698-024-00639-1.


The Multifaceted Role of Neutrophils in NSCLC in the Era of Immune Checkpoint Inhibitors.

Miao S, Rodriguez B, Gibbons D Cancers (Basel). 2024; 16(14).

PMID: 39061147 PMC: 11274601. DOI: 10.3390/cancers16142507.


References
1.
Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K . Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer. 2009; 45(11):1950-8. DOI: 10.1016/j.ejca.2009.01.023. View

2.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

3.
Kramps J, van Twisk C, van der Linden A . L-Pyroglutamyl-L-prolyl-L-valine-p-nitroanilide, a highly specific substrate for granulocyte elastase. Scand J Clin Lab Invest. 1983; 43(5):427-32. View

4.
Jagels M, Daffern P, Zuraw B, Hugli T . Mechanisms and regulation of polymorphonuclear leukocyte and eosinophil adherence to human airway epithelial cells. Am J Respir Cell Mol Biol. 1999; 21(3):418-27. DOI: 10.1165/ajrcmb.21.3.3478. View

5.
Balkwill F, Mantovani A . Inflammation and cancer: back to Virchow?. Lancet. 2001; 357(9255):539-45. DOI: 10.1016/S0140-6736(00)04046-0. View